A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate

Nasir Malik1, Rohini Manickam2, Muznabanu Bachani2

  • 1National Institute of Neurological Disorders and Stroke (NINDS), Neurotherapeutic Development Unit (NTDU), National Institutes of Health (NIH); malikn@mail.nih.gov.

Insights

This study presents a rapid, inexpensive method to screen compounds for cytotoxicity using two complementary cell-counting assays in human neural stem cells (NSCs). The strategy efficiently identifies toxic compounds early in drug discovery.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Cytotoxicity assessment is crucial for drug discovery and development.
  • In vitro cell culture models offer a cost-effective alternative to animal models for initial toxicity profiling.
  • Neural stem cells (NSCs) are vital for studying neurodevelopment and neurological disorders.

Purpose of the Study:

  • To develop and validate a dual-assay strategy for identifying compounds affecting cell growth in human neural stem cells (NSCs).
  • To establish a rapid, inexpensive, and scalable method for primary toxicity screening of drug candidates.
  • To assess the utility of complementary assays in corroborating toxicity data and potentially identifying other cellular effects.

Main Methods:

  • A tdTomato-expressing human NSC line was used to evaluate compound toxicity.
  • Two complementary assays were employed simultaneously: MTT assay (metabolic activity) and direct tdTomato+ cell counting.
  • A 96-well plate format facilitated high-throughput screening of 57 compounds in the primary assay.
  • Promising hits underwent further characterization using a six-point dose-response analysis.

Main Results:

  • The dual-assay strategy successfully identified compounds exhibiting cytotoxicity in human NSCs.
  • The two assays provided corroborating evidence for compound toxicity.
  • The simultaneous application of both assays proved to be rapid, inexpensive, and not labor-intensive.
  • Comparison of results suggested potential for identifying compounds affecting other cellular processes beyond overt toxicity.

Conclusions:

  • The described strategy offers an efficient and reliable method for early-stage cytotoxicity screening of compounds in neural stem cells.
  • This approach aids in de-risking drug development by identifying potentially toxic agents before further investment.
  • The complementary nature of the assays enhances the robustness of toxicity data and provides insights into compound-cell interactions.

Related Concept Videos